140 related articles for article (PubMed ID: 25196123)
21. Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study.
Xie Y; Mintz GS; Yang J; Doi H; Iñiguez A; Dangas GD; Serruys PW; McPherson JA; Wennerblom B; Xu K; Weisz G; Stone GW; Maehara A
JACC Cardiovasc Imaging; 2014 Apr; 7(4):397-405. PubMed ID: 24631511
[TBL] [Abstract][Full Text] [Related]
22. Relationship between palpography and virtual histology in patients with acute coronary syndromes.
Brugaletta S; Garcia-Garcia HM; Serruys PW; Maehara A; Farooq V; Mintz GS; de Bruyne B; Marso SP; Verheye S; Dudek D; Hamm CW; Farhat N; Schiele F; McPherson J; Lerman A; Moreno PR; Wennerblom B; Fahy M; Templin B; Morel MA; van Es GA; Stone GW
JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S19-27. PubMed ID: 22421227
[TBL] [Abstract][Full Text] [Related]
23. Fibrinogen in relation to degree and composition of coronary plaque on intravascular ultrasound in patients undergoing coronary angiography.
Buljubasic N; Akkerhuis KM; Cheng JM; Oemrawsingh RM; Garcia-Garcia HM; de Boer SP; Regar E; van Geuns RM; Serruys PW; Boersma E; Kardys I
Coron Artery Dis; 2017 Jan; 28(1):23-32. PubMed ID: 27755007
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes.
Wykrzykowska JJ; Mintz GS; Garcia-Garcia HM; Maehara A; Fahy M; Xu K; Inguez A; Fajadet J; Lansky A; Templin B; Zhang Z; de Bruyne B; Weisz G; Serruys PW; Stone GW
JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S10-8. PubMed ID: 22421223
[TBL] [Abstract][Full Text] [Related]
25. CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment.
Bandinelli F; Del Rosso A; Gabrielli A; Giacomelli R; Bartoli F; Guiducci S; Matucci Cerinic M
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S44-9. PubMed ID: 22691208
[TBL] [Abstract][Full Text] [Related]
26. Assessment of chemokine serum levels in epithelial ovarian cancer patients.
Falcão-Júnior JO; Teixeira-Carvalho A; Cândido EB; Lages EL; Ferreira Freitas G G; Lamaita RM; Freire Bonfim LP; Borges Salera R; Traiman P P; da Silva-Filho AL
Tumori; 2013; 99(4):540-4. PubMed ID: 24326845
[TBL] [Abstract][Full Text] [Related]
27. Coronary plaque composition assessed by intravascular ultrasound virtual histology: association with long-term clinical outcomes after heart transplantation in young adult recipients.
Tomai F; Adorisio R; De Luca L; Pilati M; Petrolini A; Ghini AS; Parisi F; Pongiglione G; Gagliardi MG
Catheter Cardiovasc Interv; 2014 Jan; 83(1):70-7. PubMed ID: 23765788
[TBL] [Abstract][Full Text] [Related]
28. The relationship between volumetric plaque components and classical cardiovascular risk factors and the metabolic syndrome a 3-vessel coronary artery virtual histology-intravascular ultrasound analysis.
Zheng M; Choi SY; Tahk SJ; Lim HS; Yang HM; Choi BJ; Yoon MH; Park JS; Hwang GS; Shin JH
JACC Cardiovasc Interv; 2011 May; 4(5):503-10. PubMed ID: 21596322
[TBL] [Abstract][Full Text] [Related]
29. Impact of positive and negative lesion site remodeling on clinical outcomes: insights from PROSPECT.
Inaba S; Mintz GS; Farhat NZ; Fajadet J; Dudek D; Marzocchi A; Templin B; Weisz G; Xu K; de Bruyne B; Serruys PW; Stone GW; Maehara A
JACC Cardiovasc Imaging; 2014 Jan; 7(1):70-8. PubMed ID: 24433710
[TBL] [Abstract][Full Text] [Related]
30. Effect of folic acid supplementation on levels of circulating Monocyte Chemoattractant Protein-1 and the presence of intravascular ultrasound derived virtual histology thin-cap fibroatheromas in patients with stable angina pectoris.
Løland KH; Bleie Ø; Strand E; Ueland PM; Nordrehaug JE; Garcia-Garcia HM; Serruys PW; Nygård O
PLoS One; 2013; 8(7):e70101. PubMed ID: 23936148
[TBL] [Abstract][Full Text] [Related]
31. Diabetes duration is associated with increased thin-cap fibroatheroma detected by intravascular ultrasound with virtual histology.
Lindsey JB; House JA; Kennedy KF; Marso SP
Circ Cardiovasc Interv; 2009 Dec; 2(6):543-8. PubMed ID: 20031772
[TBL] [Abstract][Full Text] [Related]
32. Intracoronary monocyte chemoattractant protein 1 and vascular endothelial growth factor levels are associated with necrotic core, calcium and fibrous tissue atherosclerotic plaque components: an intracoronary ultrasound radiofrequency study.
Fuchs S; Lavi I; Tzang O; Bessler H; Brosh D; Bental T; Dvir D; Einav S; Kornowski R
Cardiology; 2012; 123(2):125-32. PubMed ID: 23095175
[TBL] [Abstract][Full Text] [Related]
33. Plasma cystatin C and neutrophil gelatinase-associated lipocalin in relation to coronary atherosclerosis on intravascular ultrasound and cardiovascular outcome: Impact of kidney function (ATHEROREMO-IVUS study).
Brankovic M; Akkerhuis KM; Buljubasic N; Cheng JM; Oemrawsingh RM; Garcia-Garcia HM; Regar E; Serruys PW; van Geuns RJ; Boersma E; Kardys I
Atherosclerosis; 2016 Nov; 254():20-27. PubMed ID: 27680774
[TBL] [Abstract][Full Text] [Related]
34. Circulating acute phase proteins in relation to extent and composition of coronary atherosclerosis and cardiovascular outcome: results from the ATHEROREMO-IVUS study.
Battes LC; Akkerhuis KM; Cheng JM; Garcia-Garcia HM; Oemrawsingh RM; de Boer SP; Regar E; van Geuns RJ; Serruys PW; Boersma E; Kardys I
Int J Cardiol; 2014 Dec; 177(3):847-53. PubMed ID: 25465831
[TBL] [Abstract][Full Text] [Related]
35. Circulating levels of beta-chemokines in systemic lupus erythematosus.
Kaneko H; Ogasawara H; Naito T; Akimoto H; Lee S; Hishikawa T; Sekigawa I; Tokano Y; Takasaki Y; Hirose SI; Hashimoto H
J Rheumatol; 1999 Mar; 26(3):568-73. PubMed ID: 10090164
[TBL] [Abstract][Full Text] [Related]
36. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
Crane IJ; McKillop-Smith S; Wallace CA; Lamont GR; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1547-52. PubMed ID: 11381059
[TBL] [Abstract][Full Text] [Related]
37. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients.
Alam R; York J; Boyars M; Stafford S; Grant JA; Lee J; Forsythe P; Sim T; Ida N
Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1398-404. PubMed ID: 8616572
[TBL] [Abstract][Full Text] [Related]
38. Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention.
McPherson JA; Maehara A; Weisz G; Mintz GS; Cristea E; Mehran R; Foster M; Verheye S; Rabbani L; Xu K; Fahy M; Templin B; Zhang Z; Lansky AJ; de Bruyne B; Serruys PW; Stone GW
JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S76-85. PubMed ID: 22421234
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to periodontal pathogens are associated with coronary plaque remodeling but not with vulnerability or burden.
de Boer SP; Cheng JM; Rangé H; Garcia-Garcia HM; Heo JH; Akkerhuis KM; Meilhac O; Cosler G; Pussinen PJ; van Geuns RJ; Serruys PW; Boersma E; Kardys I
Atherosclerosis; 2014 Nov; 237(1):84-91. PubMed ID: 25233105
[TBL] [Abstract][Full Text] [Related]
40. Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.
Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Sugiyama D; Nakagawa M; Hariki H; Inoue T; Osue T; Taniguchi Y; Iwasaki M; Nishio R; Kinutani H; Konishi A; Hiranuma N; Takahashi H; Terashita D; Hirata KI
JACC Cardiovasc Interv; 2015 May; 8(6):800-811. PubMed ID: 25999102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
